New pancreatic cancer drug nearly doubles survival

In clinical trials, the drug was shown to almost double the median survival time for patients with pancreatic cancer.

US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug

By Deena Beasley and Nancy Lapid May 14 (Reuters) - U.S. cancer centers are scrambling to enroll patients in an early access ...
FierceBiotech

First-ever drug application for MDMA finally reaches FDA after near 40-year journey

Figuring out how long it's taken the Multidisciplinary Association for Psychedelic Studies' (MAPS) application to reach the FDA’s desk all depends on when you start counting. The organization was ...
Fierce Pharma

FDA floats possible approach to repurpose approved drugs under new uses

The framework would leverage existing safety data on approved drugs to provide new options to patients with unmet medical ...
JD Supra

First Drugs Selected for Price Negotiations Under The Inflation Reduction Act To Be Announced Next Week: A Recap of What That Means - The Drug Price Negotiation Program and ...

The Inflation Reduction Act’s Medicare Drug Price Negotiation Program will kick off next week. The statute sets a deadline of September 1, 2023 for the Secretary of Health and Human Services (HHS) to ...
Health Affairs

A Priority Review Voucher Program To Fuel Generic Drug Development

Millions of Americans report that they are unable to fill their prescriptions or are not taking their medications as prescribed because they cannot afford them, generating bipartisan interest in ...